HK1189012A1 - Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process - Google Patents

Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process

Info

Publication number
HK1189012A1
HK1189012A1 HK14101536.3A HK14101536A HK1189012A1 HK 1189012 A1 HK1189012 A1 HK 1189012A1 HK 14101536 A HK14101536 A HK 14101536A HK 1189012 A1 HK1189012 A1 HK 1189012A1
Authority
HK
Hong Kong
Prior art keywords
prophylaxis
compounds
treatment
pharmaceutical compositions
adhesion process
Prior art date
Application number
HK14101536.3A
Other languages
English (en)
Chinese (zh)
Inventor
米哈伊爾.根納季維奇.舒雷金
伊琳娜.亞歷山德羅芙娜.舒雷金娜
Original Assignee
法瑪西泰股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2011119848/15A external-priority patent/RU2011119848A/ru
Application filed by 法瑪西泰股份公司 filed Critical 法瑪西泰股份公司
Publication of HK1189012A1 publication Critical patent/HK1189012A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02Polyamines
    • C08G73/0206Polyalkylene(poly)amines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/0605Polycondensates containing five-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/06Polyhydrazides; Polytriazoles; Polyamino-triazoles; Polyoxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
HK14101536.3A 2011-05-17 2014-02-18 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process HK1189012A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2011119848/15A RU2011119848A (ru) 2011-05-17 2011-05-17 Способ профилактики спайкообразования
RU2011153043 2011-12-26
PCT/IB2012/052483 WO2012156938A1 (ru) 2011-05-17 2012-05-17 Соединения, фармацевтические композиции и способ профилактики и лечения спаечного процесса

Publications (1)

Publication Number Publication Date
HK1189012A1 true HK1189012A1 (en) 2014-05-23

Family

ID=47176372

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14101536.3A HK1189012A1 (en) 2011-05-17 2014-02-18 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process

Country Status (31)

Country Link
US (2) US10172952B2 (xx)
EP (2) EP2716684B1 (xx)
JP (2) JP5936683B2 (xx)
KR (2) KR20170034950A (xx)
CN (1) CN103534293B (xx)
AP (1) AP3694A (xx)
AU (3) AU2012257347A1 (xx)
BR (1) BR112013029616B1 (xx)
CA (1) CA2836268C (xx)
CL (1) CL2013003305A1 (xx)
CO (1) CO6801779A2 (xx)
CR (1) CR20130600A (xx)
CY (1) CY1122190T1 (xx)
DK (1) DK2716684T3 (xx)
DO (1) DOP2013000266A (xx)
EA (1) EA025493B1 (xx)
GE (1) GEP201706614B (xx)
HK (1) HK1189012A1 (xx)
IL (1) IL229423B (xx)
LT (1) LT2716684T (xx)
MA (1) MA35189B1 (xx)
MX (2) MX369019B (xx)
NI (1) NI201300124A (xx)
PE (1) PE20141161A1 (xx)
PL (1) PL2716684T3 (xx)
RS (1) RS59382B1 (xx)
RU (1) RU2582975C2 (xx)
SI (1) SI2716684T1 (xx)
SV (1) SV2013004582A (xx)
WO (1) WO2012156938A1 (xx)
ZA (1) ZA201308542B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2716684T3 (pl) * 2011-05-17 2020-01-31 Joint Stock Company "Pharmasyntez" Związki do profilaktyki i leczenia procesu powstawania zrostów
RU2745965C1 (ru) * 2020-11-23 2021-04-05 Галина Анатольевна Пучкина Способ профилактики послеоперационного спаечного процесса органов малого таза
RU2749435C1 (ru) * 2020-11-27 2021-06-10 Федеральное государственное бюджетное научное учреждение "Иркутский научный центр хирургии и травматологии" Способ лечения энтеральной недостаточности при воспалительных и травматических повреждениях брюшины

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003297A1 (en) * 1993-07-21 1995-02-02 Smithkline Beecham Corporation Imidazoles for treating cytokine mediated disease
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US5837719A (en) * 1995-08-10 1998-11-17 Merck & Co., Inc. 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
CA2228050A1 (en) * 1995-08-10 1997-02-20 Harold G. Selnick 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
US5894971A (en) 1998-02-02 1999-04-20 Huang; Te Chien Tool holder for attaching tools to user's hand
US6521223B1 (en) 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
PT1311488E (pt) * 2000-08-17 2009-12-30 Pfizer Ltd Imidazóis substituídos utilizados como inibidores de tafia
AU2003249977A1 (en) * 2002-07-05 2004-01-23 Axxima Pharmaceuticals Ag Imidazole compounds for the treatment of hepatitis c virus infections
JP2006519766A (ja) * 2002-12-30 2006-08-31 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 組織反応性化合物および組成物、ならびにそれらの使用法
CN101443044A (zh) * 2005-09-22 2009-05-27 哈达斯特医学研究服务与开发有限公司 治疗活性化合物的葡聚糖和阿拉伯半乳聚糖结合物
WO2008099829A1 (ja) * 2007-02-14 2008-08-21 Japan Science And Technology Agency 実験動物の腸管癒着を形成する方法、腸管癒着実験動物の製造方法、腸管癒着抑制剤のスクリーニング方法及び腸管癒着抑制剤
ES2619181T3 (es) * 2007-08-28 2017-06-23 Otago Innovation Limited Hidrogel quirúrgico
RU2363476C1 (ru) 2007-12-20 2009-08-10 Марина Сергеевна Гомон Способ профилактики образования послеоперационных спаек
WO2009103821A2 (de) * 2008-02-23 2009-08-27 Virologik Gmbh Mittel zur behandlung von virusinfektionen
US8205286B1 (en) 2008-10-21 2012-06-26 Milagros Diaz Pillow for female breasts
PL2716684T3 (pl) * 2011-05-17 2020-01-31 Joint Stock Company "Pharmasyntez" Związki do profilaktyki i leczenia procesu powstawania zrostów
CA2846143A1 (en) 2013-03-13 2014-09-13 Evan J. Falck Helmet pillow

Also Published As

Publication number Publication date
CA2836268C (en) 2018-07-03
PE20141161A1 (es) 2014-10-01
NZ618882A (en) 2016-03-31
BR112013029616B1 (pt) 2022-09-20
CN103534293B (zh) 2015-10-21
MA35189B1 (fr) 2014-06-02
AP3694A (en) 2016-04-30
CO6801779A2 (es) 2013-11-29
EP2716684B1 (en) 2019-06-26
US20190125886A1 (en) 2019-05-02
LT2716684T (lt) 2019-09-25
GEP201706614B (en) 2017-02-10
PL2716684T3 (pl) 2020-01-31
SI2716684T1 (sl) 2019-11-29
NI201300124A (es) 2014-02-25
CN103534293A (zh) 2014-01-22
BR112013029616A2 (pt) 2020-08-25
KR20170034950A (ko) 2017-03-29
US10172952B2 (en) 2019-01-08
AU2017221883A1 (en) 2017-09-28
AU2015213303A1 (en) 2015-09-03
EA201301275A1 (ru) 2014-03-31
RS59382B1 (sr) 2019-11-29
US20140079663A1 (en) 2014-03-20
EP2716684A4 (en) 2015-07-15
IL229423A0 (en) 2014-01-30
IL229423B (en) 2018-04-30
AU2012257347A1 (en) 2014-01-09
MX369019B (es) 2019-10-24
DK2716684T3 (da) 2019-09-30
US10493164B2 (en) 2019-12-03
CY1122190T1 (el) 2020-11-25
AP2013007258A0 (en) 2013-11-30
ZA201308542B (en) 2014-07-30
MX2013013409A (es) 2014-07-11
CA2836268A1 (en) 2012-11-22
JP5936683B2 (ja) 2016-06-22
SV2013004582A (es) 2018-11-12
CL2013003305A1 (es) 2014-07-18
MX2019011386A (es) 2019-10-30
JP2016175931A (ja) 2016-10-06
RU2013155582A (ru) 2015-06-27
KR20140074259A (ko) 2014-06-17
EA025493B1 (ru) 2016-12-30
CR20130600A (es) 2014-04-29
EP2716684A1 (en) 2014-04-09
WO2012156938A1 (ru) 2012-11-22
DOP2013000266A (es) 2014-06-01
RU2582975C2 (ru) 2016-04-27
EP3569636A1 (en) 2019-11-20
JP2014515057A (ja) 2014-06-26
AU2017221883B2 (en) 2019-06-20

Similar Documents

Publication Publication Date Title
HK1197400A1 (zh) 治療 的化合物
HK1218724A1 (zh) 用於治療瘻的組合物
PL2672966T3 (pl) Kompozycja farmaceutyczna, sposoby leczenia i jej zastosowania
LT2729151T (lt) Farmacinė kompozicija, gydymo būdai ir jų panaudojimas
EP2771045A4 (en) METHOD FOR REDUCING OR ELIMINATING ONE OR MORE INGREDIENTS FROM A BLOOD PRODUCT
SG11201400939YA (en) Process for the preparation of methoxymelonal
EP2758780A4 (en) METHOD OF TREATING MULTIPLE SCLEROSIS
EP2699233A4 (en) METHOD FOR TREATING SOLID TUMORS
IL228777B (en) A method for producing gypsum products
RS57395B1 (sr) Postupak za tretman čelika
HK1189012A1 (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
IL230159A0 (en) Method for the production of 2-amino-5-cyano-n,3-dimethylbenzamide
GB201121950D0 (en) Treatment process
GB201119690D0 (en) Process for the preparation of compounds
ZA201201681B (en) Dihydro-oxozolobenzodiazepinone compounds,a process for their preparation and pharmaceutical compositions containing them
PL393916A1 (pl) Sposób wytwarzania związków karbapenamowych
ME03585B (me) JEDINJENJA ZA PROFILAKSU l TRETMAN ADHEZIONOG PROCESA
ZA201309732B (en) Process for the preparation of dexlansoprazole
HUP1100534A2 (en) Pharmaceutical composition for the treatment of muscle atrophy
PL2734492T3 (pl) Sposób wytwarzania 1,1,1-trifluoropropanu
EP2712621A4 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERPROLIFERATIVE DISEASES
ZA201107792B (en) Process for the preparation of highly pure duloxetine hydrochloride
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny
PL394378A1 (pl) Sposób otrzymywania E-2-amino-4-nitrostilbenów
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds